Synthesis of non-GMP small molecules

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200622023C
Awardee
Awarding agency
Obligated
$1,141,905

Award facts

Opportunity
  • N02CM57030 Solicitation number
Contract value 20% obligated
  • $3,106,045.67 Current, with exercised options
  • $5,623,209.67 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541940 Veterinary Services
Set-aside
No set-aside
Competition
Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing
Cost Plus Award Fee
Place of performance
Santa Fe, FL 32615, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 15 · This modification deobligates the uninvoiced funds. -$714
Other Administrative Action 14 · This modification deobligates the uninvoiced arra funds. -$18,223
Funding Only Action 13 · This modification revises article b.2 to add the fixed fee owed to the contractor that was not previously funded. $30,842
Other Administrative Action 12 · Other functions ; this modification revises sections g and i, updating hhsar clauses and providing additional OFM invoicing instructions. $0
Other Administrative Action 11 · ; administrative modification, modifying article f.1. And f.2. $0
Other Administrative Action 10 · ; administrative modification, modifying article b.2., item f. $0
Exercise an Option 9 · Exercise option 1, extending the contract 6 months; providing FY2011 funding for procurement and synthesis of specific compounds. $400,000
Funding Only Action 8 $16,000
Other Administrative Action 7 · Arra::yes::arra recovery: cancer pathway dissection and combination therapies($300,000); $300,000
Supplemental Agreement for work within scope 6 · Arra::yes::arra recovery $21,000
Funding Only Action 5 $50,000
Other Administrative Action 4 $0
Funding Only Action 3 $143,000
Funding Only Action 2 $100,000
Funding Only Action 1 $25,000
Original award $75,000
Show all 16

About this award

Written by GovTribe AI ·

This is a $5,623,209.67 cost-plus-award-fee contract awarded by the National Cancer Institute to Alchem Laboratories Corporation, a for-profit pharmaceutical manufacturer in Alachua, Florida. The contract is for the synthesis of non-GMP small molecule samples to support the National Cancer Institute's research. It has an ultimate completion date of September 30, 2012.

Alchem Laboratories is also an awardee on several indefinite delivery vehicle (IDV) contracts with the National Cancer Institute and National Institute of Allergy and Infectious Diseases, including a $12 million IDV for analysis and synthesis of GMP and non-GMP drugs and formulations, and a $107 million Preclinical Services for HIV Therapeutics IDV. Additionally, the company has received a $474,451 grant from the Defense Threat Reduction Agency for research and development of small molecule inhibitors targeting the Venezuelan equine encephalitis virus. No small business set-aside was used for this contract award.

Quick answers

Who was awarded contract HHSN261200622023C?

HHSN261200622023C was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on September 29, 2006.

How much is contract HHSN261200622023C worth?

The government has obligated $1,141,905 on HHSN261200622023C. Its current value, with exercised options, is $3,106,046. Its potential value, with all options, is $5,623,210.

Was contract HHSN261200622023C competed?

The extent of competition for HHSN261200622023C was full and open competition. The government received 9 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login